General Annual Meeting (GAM)

39th General Annual Meeting of the Belgian Hematology Society - Day 2 - Closure

39th General Annual Meeting of the Belgian Hematology Society - Day 2 - Session VI : AMGINY, BeiGeneration, Gilead, PACE & SAFYHR Awards

39th General Annual Meeting of the Belgian Hematology Society - Day 2 - Satellite 3 : GSK | Infection prevention and management in the era of novel agents

39th General Annual Meeting of the Belgian Hematology Society - Day 2 - Session V : Highlight 2 | How I treat in 2024: Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia

39th General Annual Meeting of the Belgian Hematology Society - Day 2 - Satellite 2 : AstraZeneca | Navigating the increasing complexity of Chronic Lymphocytic Leukemia treatments: a practical approach

39th General Annual Meeting of the Belgian Hematology Society - Day 1 - Best Oral and Poster Awards

39th General Annual Meeting of the Belgian Hematology Society - Day 1 - Session IV : Ethics & Economy

39th General Annual Meeting of the Belgian Hematology Society - Day 1 - Session III : Pierre Stryckmans Lecture